The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Mesenchymal stem cells engineered for cancer therapy
Open accessAbstract
Recent pre-clinical and clinical studies have shown that stem cell-based therapies hold tremendous promise for the treatment of human disease. Mesenchymal stem cells (MSC) are emerging as promising anti-cancer agents which have an enormous potential to be utilized to treat a number of different cancer types. MSC have inherent tumor-trophic migratory properties, which allows them to serve as vehicles for delivering effective, targeted therapy to isolated tumors and metastatic disease. MSC have been readily engineered to express anti-proliferative, pro-apoptotic, anti-angiogenic agents that specifically target different cancer types. Many of these strategies have been validated in a wide range of studies evaluating treatment feasibility or efficacy, as well as establishing methods for real-time monitoring of stem cell migration in vivo for optimal therapy surveillance and accelerated development. This review aims to provide an in depth status of current MSC-based cancer therapies, as well as the prospects for their clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrow
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., et al. (2002) · Nature · doi:10.1038/nature00870 · Cited by 5,518
RetractedJemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
Kern, S., Eichler, H., Stoeve, J., Klüter, H., & Bieback, K. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0342 · Cited by 3,370
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Mesenchymal stem cells reside in virtually all post-natal organs and tissues
Meirelles, L. D. S., Chagastelles, P. C., & Nardi, N. B. (2006) · Journal of Cell Science · doi:10.1242/jcs.02932 · Cited by 2,485
Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Mesenchymal progenitor cells in human umbilical cord blood
Erices, A., Conget, P., & Minguell, J. J. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01986.x · Cited by 1,613
Jain, R. K., di Tomaso, E., Duda, D. G., Loeffler, J. S., Sorensen, A. G., & Batchelor, T. T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2175 · Cited by 1,405
Isolation of multipotent mesenchymal stem cells from umbilical cord blood
Lee, O. K., Kuo, T. K., Chen, W.-M., Lee, K.-D., Hsieh, S.-L., & Chen, T.-H. (2004) · Blood · doi:10.1182/blood-2003-05-1670 · Cited by 1,360
Aboody, K. S., Brown, A., Rainov, N. G., Bower, K. A., Liu, S., Yang, W., Small, J. E., Herrlinger, U., Ourednik, V., Black, P. M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.23.12846 · Cited by 1,207
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Imitola, J., Raddassi, K., Park, K. I., Mueller, F.-J., Nieto, M., Teng, Y. D., Frenkel, D., Li, J., Sidman, R. L., Walsh, C. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408258102 · Cited by 1,057
Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1874 · Cited by 1,035
Teng, Y. D., Lavik, E. B., Qu, X., Park, K. I., Ourednik, J., Zurakowski, D., Langer, R., & Snyder, E. Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052678899 · Cited by 966
Critical Parameters for the Isolation of Mesenchymal Stem Cells from Umbilical Cord Blood
Bieback, K., Kern, S., Klüter, H., & Eichler, H. (2004) · Stem Cells · doi:10.1634/stemcells.22-4-625 · Cited by 931
Romanov, Y. A., Svintsitskaya, V. A., & Smirnov, V. N. (2003) · STEM CELLS · doi:10.1634/stemcells.21-1-105 · Cited by 904
(2002) · PubMed · Cited by 903
Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery
Li, Y., Chen, J., Chen, X. G., Wang, L., Gautam, S. C., Xu, Y. X., Katakowski, M., Zhang, L. J., Lu, M., Janakiraman, N., et al. (2002) · Neurology · doi:10.1212/wnl.59.4.514 · Cited by 869
Studeny, M., Marini, F. C., Dembinski, J. L., Zompetta, C., Cabreira-Hansen, M., Bekele, B. N., Champlin, R. E., & Andreeff, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh299 · Cited by 842
Rubinstein, P., Dobrila, L., Rosenfield, R. E., Adamson, J. W., Migliaccio, G., Migliaccio, A. R., Taylor, P. E., & Stevens, C. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10119 · Cited by 819
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051921 · Cited by 747
Human Placenta‐Derived Cells Have Mesenchymal Stem/Progenitor Cell Potential
Fukuchi, Y., Nakajima, H., Sugiyama, D., Hirose, I., Kitamura, T., & Tsuji, K. (2004) · STEM CELLS · doi:10.1634/stemcells.22-5-649 · Cited by 646
Son, B., Marquez‐Curtis, L. A., Kucia, M., Wysoczynski, M., Turner, A. R., Ratajczak, J., Ratajczak, M. Z., & Janowska‐Wieczorek, A. (2006) · STEM CELLS · doi:10.1634/stemcells.2005-0271 · Cited by 641
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
Walczak, H., & Krammer, P. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4840 · Cited by 628
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
Nakamura, K., Ito, Y., Kawano, Y., Kurozumi, K., Kobune, M., Tsuda, H., Bizen, A., Honmou, O., Niitsu, Y., & Hamada, H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302276 · Cited by 597
Park, K. I., Teng, Y. D., & Snyder, E. Y. (2002) · Nature Biotechnology · doi:10.1038/nbt751 · Cited by 554
Recent progress in the battle between oncolytic viruses and tumours
Parato, K. A., Senger, D., Forsyth, P. A. J., & Bell, J. C. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1750 · Cited by 536
Can stem cells cross lineage boundaries?
Anderson, D. J., Gage, F. H., & Weissman, I. L. (2001) · Nature Medicine · doi:10.1038/86439 · Cited by 487
Sasportas, L. S., Kasmieh, R., Wakimoto, H., Hingtgen, S., van de Water, J. A. J. M., Mohapatra, G., Figueiredo, J. L., Martuza, R. L., Weissleder, R., & Shah, K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806647106 · Cited by 455
Self-citationMueller, S. M., & Glowacki, J. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1174 · Cited by 440
Teng, Y. D., Frenkel, D., Nieto, M., Müeller, F.-J., Park, K. I., Raddassi, K., Imitola, J., Li, J., Sidman, R. L., Walsh, C. A., et al. (2004) · Cited by 421
Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
Loebinger, M. R., Eddaoudi, A., Davies, D., & Janes, S. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4698 · Cited by 417
Corsten, M. F., Miranda, R., Kasmieh, R., Krichevsky, A. M., Weissleder, R., & Shah, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1045 · Cited by 406
Self-citationSuppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model
Qiao, L., Xu, Z., Zhao, T., Zhao, Z., Shi, M., Zhao, R. C., Ye, L., & Zhang, X. (2008) · Cell Research · doi:10.1038/cr.2008.40 · Cited by 388
François, S., Bensidhoum, M., Mouiseddine, M., Mazurier, C., Allenet, B., Semont, A., Frick, J., Saché, A., Bouchet, S., Thierry, D., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0260 · Cited by 382
Goodwin, H. S., Bicknese, A. R., Chien, S.-N., Bogucki, B. D., Oliver, D. A., Quinn, C. O., & Wall, D. A. (2001) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.2001.v7.pm11760145 · Cited by 380
Visualizing the kinetics of tumor-cell clearance in living animals
Sweeney, T. J., Mailänder, V., Tucker, A. A., Olomu, A. B., Zhang, W., Cao, Y.-A., Negrin, R. S., & Contag, C. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12044 · Cited by 350
Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells
Otsu, K., Das, S., Houser, S. D., Quadri, S. K., Bhattacharya, S., & Bhattacharya, J. (2009) · Blood · doi:10.1182/blood-2008-09-176198 · Cited by 344
Kurozumi, K., Nakamura, K., Tamiya, T., Kawano, Y., Kobune, M., Hirai, S., Uchida, H., Sasaki, K., Ito, Y., Kato, K., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.10.012 · Cited by 339
The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma.
Ehtesham, M., Kabos, P., Kabosova, A., Neuman, T., Black, K. L., & Yu, J. S. (2002) · PubMed · Cited by 308
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
Komarova, S., Kawakami, Y., Stoff-Khalili, M. A., Curiel, D. T., & Pereboeva, L. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0334 · Cited by 302
Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia
Liu, H. (2006) · Brain · doi:10.1093/brain/awl207 · Cited by 291
Oncolytic viral therapies – the clinical experience
Aghi, M., & Martuza, R. L. (2005) · Oncogene · doi:10.1038/sj.onc.1209037 · Cited by 288
Mesenchymal Stem Cells Derived from Human Adipose Tissues Favor Tumor Cell Growth in vivo
Yu, J. M., Jun, E. S., Bae, Y. C., & Jung, J. S. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0181 · Cited by 271
Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma
Sonabend, A. M., Ulasov, I. V., Tyler, M. A., Rivera, A. A., Mathis, J. M., & Lesniak, M. S. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0758 · Cited by 254
Bexell, D., Gunnarsson, S., Tormin, A., Darabi, A., Gisselsson, D., Roybon, L., Scheding, S., & Bengzon, J. (2009) · Molecular Therapy · doi:10.1038/mt.2008.229 · Cited by 248
Chawla‐Sarkar, M., Leaman, D. W., & Borden, E. C. (2001) · PubMed · Cited by 245
Human mesenchymal stem cells isolated from the umbilical cord
Qiao, C., Xu, W., Zhu, W., Hu, J., Qian, H., Yin, Q., Jiang, R., Yan, Y., Mao, F., Yang, H., et al. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2007.08.002 · Cited by 241
Yong, R. L., Shinojima, N., Fueyo, J., Gumin, J., Vecil, G. G., Marini, F. C., Bogler, O., Andreeff, M., & Lang, F. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3873 · Cited by 235
Ma, W., Fitzgerald, W., Liu, Q.-Y., O'Shaughnessy, T. J., Maric, D., Lin, H. J., Alkon, D. L., & Barker, J. L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.10.016 · Cited by 231
The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo
Lu, Y.-R., Yuan, Y., Wang, X.-J., Wei, L.-L., Chen, Y.-N., Cong, C., Li, S.-F., Long, D., Tan, W.-D., Mao, Y.-Q., et al. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.2.5296 · Cited by 225
R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways
Cao, Y., Cao, R., & Hedlund, E.-M. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0337-z · Cited by 215
Stoff-Khalili, M. A., Rivera, A. A., Mathis, J. M., Banerjee, N. S., Moon, A. S., Hess, A., Rocconi, R. P., Numnum, T. M., Everts, M., Chow, L. T., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9449-8 · Cited by 205
Ren, C., Kumar, S., Chanda, D., Kallman, L., Chen, J., Mountz, J. D., & Ponnazhagan, S. (2008) · Gene Therapy · doi:10.1038/gt.2008.101 · Cited by 202
Chang, Y.-J., Shih, D. T.-B., Tseng, C.-P., Hsieh, T.-B., Lee, D.-C., & Hwang, S.-M. (2006) · Stem Cells · doi:10.1634/stemcells.2004-0308 · Cited by 197
Ren, C., Kumar, S., Chanda, D., Chen, J., Mountz, J. D., & Ponnazhagan, S. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0084 · Cited by 196
In Vivo Tracking of Neural Progenitor Cell Migration to Glioblastomas
Tang, Y., Shah, K., Messerli, S. M., Snyder, E., Breakefield, X., & Weissleder, R. (2003) · Human Gene Therapy · doi:10.1089/104303403767740786 · Cited by 194
Self-citationCavarretta, I. T., Altanerova, V., Matuskova, M., Kucerova, L., Culig, Z., & Altaner, C. (2010) · Molecular Therapy · doi:10.1038/mt.2009.237 · Cited by 186
Glioma therapy and real‐time imaging of neural precursor cell migration and tumor regression
Shah, K., Bureau, E., Kim, D., Yang, K., Tang, Y., Weissleder, R., & Breakefield, X. O. (2005) · Annals of Neurology · doi:10.1002/ana.20306 · Cited by 182
Self-citationImmunocompatibility and biocompatibility of cell delivery systems
Řı́hová, B. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00054-5 · Cited by 174
Chen, X., Lin, X., Zhao, J., Shi, W., Zhang, H., Wang, Y., Kan, B., Du, L., Wang, B., Wei, Y., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.3 · Cited by 173
Mesenchymal Stem Cells in Cancer: Tumor-Associated Fibroblasts and Cell-Based Delivery Vehicles
Hall, B., Dembinski, J., Sasser, A., Studeny, M., Andreeff, M., & Marini, F. (2007) · International Journal of Hematology · doi:10.1532/ijh97.06230 · Cited by 171
Targeted Delivery of CX3CL1 to Multiple Lung Tumors by Mesenchymal Stem Cells
Xin, H., Kanehira, M., Mizuguchi, H., Hayakawa, T., Kikuchi, T., Nukiwa, T., & Saijo, Y. (2007) · STEM CELLS · doi:10.1634/stemcells.2006-0461 · Cited by 164
NK4 (HGF‐antagonist/angiogenesis inhibitor) in cancer biology and therapeutics
Matsumoto, K., & Nakamura, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01440.x · Cited by 158
Gao, P., Ding, Q., Wu, Z., Jiang, H., & Fang, Z. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.08.031 · Cited by 158
Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells
Kanehira, M., Xin, H., Hoshino, K., Maemondo, M., Mizuguchi, H., Hayakawa, T., Matsumoto, K., Nakamura, T., Nukiwa, T., & Saijo, Y. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701079 · Cited by 156
Miletić, H., Fischer, Y., Litwak, S. A., Giroglou, T., Waerzeggers, Y., Winkeler, A., Li, H., Himmelreich, U., Lange, C., Stenzel, W., et al. (2007) · Molecular Therapy · doi:10.1038/mt.sj.6300155 · Cited by 155
Seo, S. H., Kim, K. S., Park, S. H., Suh, Y. S., Kim, S. J., Jeun, S.-S., & Sung, Y. C. (2011) · Gene Therapy · doi:10.1038/gt.2010.170 · Cited by 148
Johns, T. G., Mackay, I. R., Callister, K. A., Hertzog, P. J., Devenish, R. J., & Linnance, A. W. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.15.1185 · Cited by 148
Hyaluronic acid hydrogel immobilized with RGD peptides for brain tissue engineering
Cui, F. Z., Tian, W., Hou, S., Xu, Q., & Lee, I.-S. (2006) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-006-0615-7 · Cited by 145
Danks, M. K., Yoon, K. J., Bush, R. A., Remack, J. S., Wierdl, M., Tsurkan, L. G., Kim, S. U., Garcia, E. P., Metz, M. Z., Najbauer, J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3607 · Cited by 142
Kim, S. M., Oh, J. H., Park, S. A., Ryu, C. H., Lim, J. Y., Kim, D., Chang, J. W., Oh, W., & Jeun, S. (2010) · Stem Cells · doi:10.1002/stem.543 · Cited by 141
Maestroni, G. J. M., Hertens, E., & Gallì, P. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050322 · Cited by 140
Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare
Corsten, M. F., & Shah, K. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70099-8 · Cited by 138
Self-citationPEX-Producing Human Neural Stem Cells Inhibit Tumor Growth in a Mouse Glioma Model
Kim, S., Cargioli, T. G., Machluf, M., Yang, W., Sun, Y., Al-Hashem, R., Kim, S. U., Black, P. M., & Carroll, R. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0371 · Cited by 134
Recent Advances in Anti-Angiogenic Therapy of Cancer
Samant, R. S., & Shevde, L. A. (2011) · Oncotarget · doi:10.18632/oncotarget.234 · Cited by 134
Shifting emphasis from pharmacogenomics to theragnostics
Özdemir, V., Williams–Jones, B., Glatt, S. J., Tsuang, M. T., Lohr, J. B., & Reist, C. (2006) · Nature Biotechnology · doi:10.1038/nbt0806-942 · Cited by 130
Emerging use of stem cells in regenerative medicine
Teo, A. K. K., & Vallier, L. (2010) · Biochemical Journal · doi:10.1042/bj20100102 · Cited by 112
Delcroix, G. J.-R., Jacquart, M., Lemaire, L. P., Sindji, L., Franconi, F., Jeune, J. L., & Montero‐Menei, C. N. (2008) · Brain Research · doi:10.1016/j.brainres.2008.12.013 · Cited by 111
Marrow Stromal Cells for Interleukin-2 Delivery in Cancer Immunotherapy
Stagg, J., Lejeune, L., Paquin, A., & Galipeau, J. (2004) · Human Gene Therapy · doi:10.1089/104303404323142042 · Cited by 111
Approaches to Utilize Mesenchymal Progenitor Cells as Cellular Vehicles
Pereboeva, L., Komarova, S., Mikheeva, G., Krasnykh, V. N., & Curiel, D. T. (2003) · Stem Cells · doi:10.1634/stemcells.21-4-389 · Cited by 110
Wei, J., Blum, S., Unger, M. M., Jármy, G., Lamparter, M., Geishauser, A., Vlastos, G., Chan, G., Fischer, K., Rattat, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00116-3 · Cited by 109
Viability and differentiation of neural precursors on hyaluronic acid hydrogel scaffold
Pan, L., Ren, Y., Cui, F., & Xu, Q. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22142 · Cited by 109
Momin, E. N., Vela, G., Zaidi, H. A., & Quiñones‐Hinojosa, A. (2010) · Current Immunology Reviews · doi:10.2174/157339510791111718 · Cited by 106
Ikeda, N., Nonoguchi, N., Zhao, M., Watanabe, T., Kajimoto, Y., Furutama, D., Kimura, F., Dezawa, M., Coffin, R. S., Otsuki, Y., et al. (2005) · Stroke · doi:10.1161/01.str.0000190006.88896.d3 · Cited by 106
Power, A., & Bell, J. C. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300098 · Cited by 105
Toward Brain Tumor Gene Therapy Using Multipotent Mesenchymal Stromal Cell Vectors
Bexell, D., Scheding, S., & Bengzon, J. (2010) · Molecular Therapy · doi:10.1038/mt.2010.58 · Cited by 103
Biomimetic material systems for neural progenitor cell-based therapy
Potter, W. (2007) · Frontiers in bioscience · doi:10.2741/2721 · Cited by 103
Kadambi, A., Carreira, C. M., Yun, C., Padera, T. P., Dolmans, D. E. J. G. J., Carmeliet, P., Fukumura, D., & Jain, R. K. (2001) · PubMed · Cited by 101
Mohr, A., Albarenque, S. M., Deedigan, L., Yu, R., Reidy, M., Fulda, S., & Zwacka, R. M. (2010) · Stem Cells · doi:10.1002/stem.533 · Cited by 100
Mueller, L. P., Luetzkendorf, J., Widder, M., Nerger, K., Caysa, H., & Mueller, T. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.68 · Cited by 98
Shah, K., Hingtgen, S., Kasmieh, R., de Figueiredo, J. L., García-García, E., Martínez-Serrano, A., Breakefield, X. O., & Weissleder, R. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0296-08.2008 · Cited by 98
Self-citationLuther-Wyrsch, A., Carbonare, V. D., Jansen, W., Chklovskaia, E., Nissen, C., Surbek, D., Holzgreve, W., Tichelli, A., & Wodnar‐Filipowicz, A. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00059-4 · Cited by 96
Reversal of Tumor-Mediated Immunosuppression
Vieweg, J., Su, Z. Z., Dahm, P., & Kusmartsev, S. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1924 · Cited by 93
Bentzon, J. F., Stenderup, K., Hansen, F. D., Schrøder, H. D., Abdallah, B. M., Jensen, T. G., & Kassem, M. S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.072 · Cited by 92
Mesenchymal Stem Cells: New Approaches for the Treatment of Neurological Diseases
Momin, E. N., Mohyeldin, A., Zaidi, H. A., Vela, G., & Quiñones‐Hinojosa, A. (2010) · Current Stem Cell Research & Therapy · doi:10.2174/157488810793351631 · Cited by 91
Neo-Organoid of Marrow Mesenchymal Stromal Cells Secreting Interleukin-12 for Breast Cancer Therapy
Eliopoulos, N., Francois, M., Boivin, M.-N., Martineau, D., & Galipeau, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0160 · Cited by 90
Knoop, K., Kolokythas, M., Klutz, K., Willhauck, M. J., Wunderlich, N., Draganovici, D., Zach, C., Gildehaus, F., Böning, G., Göke, B., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.93 · Cited by 90
Dwyer, R. M., Ryan, J., Havelin, R. J., Morris, J. C., Miller, B. W., Liu, Z., Flavin, R., O’Flatharta, C., Foley, M. J., Barrett, H. H., et al. (2011) · Stem Cells · doi:10.1002/stem.665 · Cited by 89
Inducible Release of TRAIL Fusion Proteins from a Proapoptotic Form for Tumor Therapy
Shah, K., Tung, C., Yang, K. S., Weissleder, R., & Breakefield, X. O. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3516 · Cited by 87
Self-citationImaging Gene Expression in Human Mesenchymal Stem Cells: From Small to Large Animals
Willmann, J. K., Paulmurugan, R., Rodriguez-Porcel, M. G., Stein, W., Brinton, T. J., Connolly, A. J., Nielsen, C. H., Lutz, A. M., Lyons, J. K., Ikeno, F., et al. (2009) · Radiology · doi:10.1148/radiol.2513081616 · Cited by 78
Maeurer, M. J., Martin, D. M., Castelli, C., Elder, E. M., Leder, G. H., Storkus, W. J., & Lotze, M. T. (1995) · Cancer Immunology Immunotherapy · doi:10.1007/bf01527407 · Cited by 76
Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors
van Eekelen, M., Sasportas, L. S., Kasmieh, R., Yip, S. S. F., Figueiredo, J.-L., Louis, D. N., Weissleder, R., & Shah, K. (2010) · Oncogene · doi:10.1038/onc.2010.75 · Cited by 72
Self-citationDirecting systemic oncolytic viral delivery to tumors via carrier cells☆
Nakashima, H., Kaur, B., & Chiocca, E. A. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.02.004 · Cited by 70
Gunnarsson, S., Bexell, D., Svensson, A., Siesjö, P., Darabi, A., & Bengzon, J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.10.017 · Cited by 66
Xu, X., Yang, G., Zhang, H., & Prestwich, G. D. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.07.006 · Cited by 65
Molecular Mechanisms and Therapeutic Development of Angiogenesis Inhibitors
Cao, Y. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00004-3 · Cited by 64
Cytokine gene therapy for malignant glioma
Okada, H., & Pollack, I. F. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.10.1609 · Cited by 64
Cellular multiparametric MRI of neural stem cell therapy in a rat glioma model
Brekke, C., Williams, S., Price, J., Thorsen, F. A., & Modo, M. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.06.006 · Cited by 59
Interferon and Malignant Disease - How Does it Work and Why Doesn't it Always?
Grandér, D., & Einhorn, S. (1998) · Acta Oncologica · doi:10.1080/028418698430548 · Cited by 58
Hingtgen, S., Kasmieh, R., van de Water, J. A. J. M., Weissleder, R., & Shah, K. (2010) · Stem Cells · doi:10.1002/stem.313 · Cited by 56
Self-citationMultimodal Imaging of Neural Progenitor Cell Fate in Rodents
Waerzeggers, Y., Klein, M., Miletić, H., Himmelreich, U., Li, H., Monfared, P., Herrlinger, U., Hoehn, M., Coenen, H. H., Weller, M., et al. (2008) · Molecular Imaging · doi:10.2310/7290.2008.0010 · Cited by 52
MRI tracking of intravenously transplanted human neural stem cells in rat focal ischemia model
Song, M., Kim, Y. J., Kim, Y.-H., Ryu, S., Song, I. C., Kim, S. U., & Yoon, B.-W. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.03.006 · Cited by 49
Intratracheal Delivery of CX3CL1-Expressing Mesenchymal Stem Cells to Multiple Lung Tumors
Xin, H., Sun, R., Kanehira, M., Takahata, T., Itoh, J., Mizuguchi, H., & Saijo, Y. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00059 · Cited by 48
Roelants, V., Labar, D., de Meester, C., Havaux, X., Tabilio, A., Gambhir, S. S., Ianni, M. D., Bol, A., Bertrand, L., & Vanoverschelde, J. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.052175 · Cited by 43
Tracking Normalization of Brain Tumor Vasculature by Magnetic Imaging and Proangiogenic Biomarkers
Hormigo, A., Gutin, P. H., & Rafii, S. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.008 · Cited by 36
Growth‐inhibitory activity of interferon‐beta against human colorectal carcinoma cell lines
Wong, V. L. Y., Rieman, D. J., Aronson, L., Dalton, B. J., GREIG, R. G., & Anzano, M. A. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430331 · Cited by 35
Can neural stem cells be used as therapeutic vehicles in the treatment of brain tumors?
Noble, M. (2000) · Nature Medicine · doi:10.1038/74610 · Cited by 33
Eliopoulos, N., Lejeune, L., Martineau, D., & Galipeau, J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.004 · Cited by 30
Adult Stem Cell Treatments for Diseases?
Smith, S. D. B., Neaves, W. B., & Teitelbaum, S. L. (2006) · Science · doi:10.1126/science.1129987 · Cited by 26
Imaging Neural Stem Cell Fate in Mouse Model of Glioma
Shah, K. (2009) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc05a01s8 · Cited by 8
Self-citationDwyer, R. M., Ryan, J., Havelin, R. J., Morris, J. C., O’Flatharta, C., Miller, B. W., Liu, Z., Foley, M. J., Barrett, H. H., Murphy, M. J., et al. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-5392 · Cited by 2
Cited by
Mesenchymal Stem Cell Immunomodulation: Mechanisms and Therapeutic Potential
Song, N., Scholtemeijer, M., & Shah, K. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.06.009 · Cited by 948
Self-citationPascucci, L., Coccè, V., Bonomi, A., Ami, D., Ceccarelli, P., Ciusani, E., Viganò, L., Locatelli, A., Sisto, F., Doglia, S. M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.042 · Cited by 846
Progress in brain targeting drug delivery system by nasal route
Khan, A. R., Liu, M., Khan, M. W., & Zhai, G. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.001 · Cited by 402
Bronckaers, A., Hilkens, P., Martens, W., Gervois, P., Ratajczak, J., Struys, T., & Lambrichts, I. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.013 · Cited by 354
TRAIL on trial: preclinical advances in cancer therapy
Stuckey, D. W., & Shah, K. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.08.007 · Cited by 276
Self-citation
Metadata
- Authors
- Shah, K.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 64
- Issue
- 8
- Pages
- 739-748
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2080694397
- Cited by
- 322
- References
- 125
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.